Helicobacter Pylori Testing Market revenue to cross USD 632 Mn by 2027: Global Market Insights Inc.

Major helicobacter pylori testing market players include Abbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, and Medline Industries, Inc.

SELBYVILLE, Del., Dec. 13, 2021 /PRNewswire/ -- The helicobacter pylori testing market size is anticipated to record a valuation of USD 632 million by 2027, according to the most recent study by Global Market Insights Inc. The incidence of gastric diseases is significantly higher in the elderly population as aging increases the risk of H. pylori infection. Increased age leads to the thinning of the stomach lining, thus allowing bacteria to pass through protective lining that contributes to the growing prevalence among older people.

Further, peptic ulcers cause considerable morbidity and mortality in older people. According to the World Health Organization, the population percentage aged 60 and above is expected to be 13.7% in 2030 and 20.3% in 2050 in the WHO south-east Asia region. Due to declined functional abilities, older people face several health concerns that increase the need to improve access to healthcare services across the region. With the rising number of older people, the demand for primary care services including screening, assessment, and management of clinical and functional comorbidities is increasing.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4408 

Invasive H. pylori test segment held 44% of the helicobacter pylori testing market share in 2020. Technological advancements in invasive testing leading to introduction of advanced diagnostic techniques such as PCR and molecular diagnostics is projected to stimulate the segment growth. With the newer technologies, the field of invasive H. pylori diagnosis is also evolving. One of the recent advancements in H. pylori testing include the use of progressive computer technologies comprising artificial intelligence (AI). This is to enhance the quality of the diagnosis, provide precision, and predict disease progression. These technologies have been benchmarked based on factors such as cost, implementation, and preference. Further, polymerase chain reaction (PCR) is being widely used to detect H. pylori in gastric biopsies, dental plaque and faeces that will further advance the invasive approach for disease diagnosis, thus augmenting the segment expansion.  

The point-of-care (POC) test segment in the helicobacter pylori testing market is predicted to witness 12.3% growth rate through 2027 led by the higher adoption of advanced devices at healthcare facilities. The point-of-care testing (PoCT) has steadily increased over the years driven by changes in healthcare delivery aimed at offering affordable healthcare near to the patient's home. Availability of testing devices allowing ease and accuracy at point-of-care facilities have stimulated the industry growth. These devices are designed to assist clinicians or physicians in the decision-making of disease treatment.

The helicobacter pylori testing market for clinics segment is estimated to reach more than USD 87 million by 2027. Growing number of clinics provides advanced diagnostic services will lead to high preference towards these facilities. Access to quality healthcare at effective cost, easy accessibility and reliability and availability of skilled professionals to foster the segment revenue in the coming years. The growing number of urgent care clinics owing to patient preference for convenience and affordability is increasing the product demand. Furthermore, rising awareness regarding the helicobacter pylori test along with technological advancements is slated to fuel the product acceptance in clinics significantly in the coming years.  

China helicobacter pylori testing market accounted for 26% of revenue share in 2020 and will exceed USD 41 million by 2027. The high prevalence of gastric ulcers, gastritis, and gastric cancer coupled with rapidly aging population in the China is driving the demand for H. pylori testing. Poor sanitary conditions and healthcare infrastructure in China is further set to spur the usage of these tests. Similarly, various market players in China have recently introduced sequencing and analysis instruments in order to tackle the increasing complexity of disease diagnosis. Several companies are focusing on involvement of technologies comprising quantitative real-time polymerase chain reaction (qPCR) and digital PCR (dPCR) for DNA detection. Owing to these product advancements, the H. pylori testing is being widely adopted to monitor the eradication effectiveness in the country.

Some of the major players operating in the helicobacter pylori testing market are Abbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, and Medline Industries, Inc. These companies adopt strategic initiatives such as partnerships, collaborations, new product launches and commercial expansion to bolster their product portfolio and market presence.

Request for customization of this research report @ 

https://www.gminsights.com/roc/4408 

Table of Contents (ToC) of the report:

Chapter 3 Helicobacter Pylori Testing Market Insights

3.1  Industry segmentation

3.2  Industry landscape, 2016 – 2027 (USD Million)

3.3  Industry impact factors

3.3.1  Growth drivers

3.3.2  Industry pitfalls & challenges

3.4  Growth potential analysis

3.4.1  By test type

3.4.2  By method

3.4.3  By end-use

3.5  COVID-19 impact analysis

3.6  Regulatory landscape

3.7  Reimbursement scenario

3.8  Technology landscape

3.9  Pricing analysis

3.10  Porter's analysis

3.11  Competitive landscape, 2020

3.12  PESTEL analysis

Browse Complete Table of Contents (ToC) @

https://www.gminsights.com/toc/detail/helicobacter-pylori-testing-market 

About Global Market Insights Inc.

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Photo: https://mma.prnewswire.com/media/1708134/Helicobacter_Pylori_Testing_Market.jpg

Logo: https://mma.prnewswire.com/media/661916/GMI.jpg